M. Hussain Et Al. , "Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162)," JOURNAL OF CLINICAL ONCOLOGY , vol.24, no.24, pp.3984-3990, 2006
Hussain, M. Et Al. 2006. Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162). JOURNAL OF CLINICAL ONCOLOGY , vol.24, no.24 , 3984-3990.
Hussain, M., Tangen, C. M., Higano, C., Schelhammer, P. F., Faulkner, J., Crawford, E. D., ... Wilding, G.(2006). Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162). JOURNAL OF CLINICAL ONCOLOGY , vol.24, no.24, 3984-3990.
Hussain, Maha Et Al. "Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162)," JOURNAL OF CLINICAL ONCOLOGY , vol.24, no.24, 3984-3990, 2006
Hussain, Maha Et Al. "Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162)." JOURNAL OF CLINICAL ONCOLOGY , vol.24, no.24, pp.3984-3990, 2006
Hussain, M. Et Al. (2006) . "Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162)." JOURNAL OF CLINICAL ONCOLOGY , vol.24, no.24, pp.3984-3990.
@article{article, author={Maha Hussain Et Al. }, title={Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162)}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2006, pages={3984-3990} }